Cancer-associated thrombosis: the role of inherited thrombophilia

Blood Coagul Fibrinolysis. 2024 Sep 1;35(6):297-302. doi: 10.1097/MBC.0000000000001317. Epub 2024 Jul 26.

Abstract

Cancer-associated thrombosis (CAT) is a common complication and a major cause of morbidity and mortality in patients with active cancers. CAT is common in various malignancies, particularly pancreatic, ovarian, gastric, colorectal, and hematologic cancers. In fact, CAT is a complicated multifactorial complication that may be influenced by the type of cancer as well as by the genetic background and inheritance of thrombophilic variants and elevated concentrations of coagulation factors. Several studies have shown the prominent role of inherited thrombophilias, such as prothrombin 20210, factor V Leiden, factor XIII Val34Leu, MTHFR C677T, in the occurrence of CAT, while others have found no correlation between them and CAT. In the present review, we have attempted to investigate the possible role of inherited thrombophilia in the occurrence of CAT.

Publication types

  • Review

MeSH terms

  • Factor V / genetics
  • Humans
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Neoplasms* / blood
  • Neoplasms* / complications
  • Neoplasms* / genetics
  • Thrombophilia* / blood
  • Thrombophilia* / complications
  • Thrombophilia* / genetics
  • Thrombosis* / etiology

Substances

  • Factor V
  • Methylenetetrahydrofolate Reductase (NADPH2)

Supplementary concepts

  • Thrombophilia, hereditary